Efficacy of carbamazepine against neuroleptic-induced akathisia in treatment with perospirone: Case series

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 2, 2005, Pages 343-346

  Masui, Takuya ^a   Kusumi, Ichiro ^a   Takahashi, Yoshito ^b   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sapporo Municipal General Hospital   (Japan)

Author keywords

Akathisia; Carbamazepine; Perospirone; Pharmacokinetics; Schizophrenia

Indexed keywords

ANTIHISTAMINIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIPERIDEN; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; ETHYL LOFLAZEPATE; ETIZOLAM; MIANSERIN; NEUROLEPTIC AGENT; OLANZAPINE; OXYPERTINE; PEROSPIRONE; PINDOLOL; QUETIAPINE; RISPERIDONE; SULPIRIDE;

ADULT; AKATHISIA; AMNESIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DROWSINESS; DRUG EFFICACY; DRUG MECHANISM; ELECTROCONVULSIVE THERAPY; EXPERIENCE; FEMALE; HUMAN; MALE; NEUROLEPTIC INDUCED DEFICIT SYNDROME; SCHIZOPHRENIA;

EID: 13444305197     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.11.022     Document Type: Article

References (16)

1. American Psychiatric Association DSM-IV: diagnostic and statistical manual of mental disorders 4th ed. 1994 APA Washington, DC
2. L.A. Arvanitis, and B.G. Miller Multiple fixed doses of "Seroquel"(quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group Biol. Psychiatry 42 1997 233 246
3. T. Barnes Barnes akathisia rating scale Br. J. Psychiatry 54 1989 545 572
4. W.S.D. Chung, and H.F.K. Chiu Drug-induced akathisia revisited Br. J. Clin. Pract. 50 1996 270 278
5. W. Fleischhacker, S. Roth, and J. Kane The pharmacological treatment of neuroleptic induced akathisia J. Clin. Pharmacol. 10 1990 12 20
6. T. Friss, T.R. Christensen, and J. Gerlach Sodium valproate and biperiden in neuroleptic induced akathisia, Parkinsonism and hyperkinesia: a double blind cross over study with placebo Acta Psychiatr. Scand. 67 1982 178 187
7. M.S. Hamilton, and L.A. Opler Akathisia, suicidality and fluoxetine J. Clin. Psychiatry 53 1992 401 406
8. M. Jauss, J. Schroder, J. Pantel, S. Bachmann, I. Gerdsen, and C. Mundt Severe akathisia during olanzapine treatment of acute schizophrenia Pharmacopsychiatry 31 1998 146 148
9. R.M. Lane SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment J. Psychopharmacol. 12 1998 192 214
10. J.F. Linpinski Jr., G.S. Zubrenko, B.M. Cohen, and P.J. Barreira Propranolol in the treatment of neuroleptic-induced akathisia Am. J. Psychiatry 141 1984 412 415
11. C.H. Miller, and W.W. Fleischhacker Managing antipsychotic-induced acute and chronic akathisia Drug Safety 22 2000 73 81
12. Y. Mizuno, N. Tani, S. Komuro, H. Kanamaru, and I. Nakatsuka In vitro metabolism of perospirone in rat, monkey, and human liver microsomes Eur. J. Drug Metab. Pharmacokinet. 28 2003 59 65
13. M. Poyurovsky, M. Shardorodsky, C. Fuchs, M. Schneidman, and A. Weizman Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin. Double-blind, placebo-controlled study Br. J. Psychiatry 174 1999 238 242
14. E. Spina, and E. Perucca Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs Epilepsia 43 Suppl. 2 2002 37 44
15. Y. Takahashi, I. Kusumi, T. Ishikane, and T. Koyama In vivo occupation of dopamine D1, D2 and serotonin2A receptors by novel antipsychotic drug, SM-9018 and its metabolite, in rat brain J. Neural Transm. 105 1998 181 191
16. N. Yasui-Furukori, T. Kondo, K. Mihara, A. Suzuki, Y. Inoue, and S. Kaneko Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patients J. Clin. Psychopharmacol. 23 2003 435 440